SEARCH

SEARCH BY CITATION

References

  • Arai A, Chano T, Futami K, Furuichi Y, Ikebuchi K, Inui T, Tameno H, Ochi Y, Shimada T, Hisa Y, Okabe H (2011) RECQL1 and WRN proteins are potential therapeutic targets in head and neck squamous cell carcinoma. Cancer Res. 71, 45984607.
  • Cairns RA, Harris IS, Mak TW (2011) Regulation of cancer cell metabolism. Nat. Rev. Cancer 11, 8595.
  • Campisi J, d'Adda di Fagagna F (2007) Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 8, 729740.
  • Crabbe L, Verdun RE, Haggblom CI, Karlseder J (2004) Defective telomere lagging strand synthesis in cells lacking WRN helicase activity. Science 306, 19511953.
  • Dickinson BC, Chang CJ (2008) A targetable fluorescent probe for imaging hydrogen peroxide in the mitochondria of living cells. J. Am. Chem. Soc. 130, 96389639.
  • Dickinson BC, Peltier J, Stone D, Schaffer DV, Chang CJ (2011) Nox2 redox signaling maintains essential cell populations in the brain. Nat. Chem. Biol. 7, 106112.
  • Duvel K, Yecies JL, Menon S, Raman P, Lipovsky AI, Souza AL, Triantafellow E, Ma Q, Gorski R, Cleaver S, Vander Heiden MG, MacKeigan JP, Finan PM, Clish CB, Murphy LO, Manning BD (2010) Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol. Cell 39, 171183.
  • Epstein CJ, Martin GM, Schultz AL, Motulsky AG (1966) Werner's syndrome. A review of its symptomatology, natural history, pathological features, genetics and relationship to the natural aging process. Medicine 45, 177221.
  • Finkel T (2012) Signal transduction by mitochondrial oxidants. J. Biol. Chem. 287, 44344440.
  • Fukuchi K, Martin GM, Monnat RJ (1989) Mutator phenotype of Werner syndrome is characterized by extensive deletions. Proc. Natl Acad. Sci. USA 86, 58935897.
  • Futami K, Ishikawa Y, Goto M, Furuichi Y, Sugimoto M (2008) Role of Werner syndrome gene product helicase in carcinogenesis and in resistance to genotoxins by cancer cells. Cancer Sci. 99, 843848.
  • Goto M, Miller RW, Ishikawa Y, Sugano H (1996) Excess of rare cancers in Werner's syndrome (adult progeria). Cancer Epidemiol. Biomark. Prev. 5, 239246.
  • Hewitt G, Jurk D, Marques FD, Correia-Melo C, Hardy T, Gackowska A, Anderson R, Taschuk M, Mann J, Passos JF (2012) Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat. Commun. 3, 708.
  • Kirito K, Hu Y, Komatsu N (2009) HIF-1 prevents the overproduction of mitochondrial ROS after cytokine stimulation through induction of PDK-1. Cell Cycle 8, 28442849.
  • Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL (2001) HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell. Biol. 21, 39954004.
  • Li B, Jog SP, Reddy S, Comai L (2008) WRN controls formation of extrachromosomal telomeric circles and is required for TRF2DeltaB-mediated telomere shortening. Mol. Cell. Biol. 28, 18921904.
  • Li B, Reddy S, Comai L (2009) Sequence-specific processing of telomeric 3′ overhangs by the Werner syndrome protein exonuclease activity. Aging (Albany NY) 1, 289302.
  • Li B, Reddy S, Comai L (2011) Depletion of Ku70/80 reduces the levels of extrachromosomal telomeric circles and inhibits proliferation of ALT cells. Aging (Albany NY) 3, 395406.
  • Lombard DB, Beard C, Johnson B, Marciniak RA, Dausman J, Bronson R, Buhlmann JE, Lipman R, Curry R, Sharpe A, Jaenisch R, Guarente L (2000) Mutations in the WRN gene in mice accelerate mortality in a p53-null background. Mol. Cell. Biol. 20, 32863291.
  • Machwe A, Xiao L, Orren DK (2004) TRF2 recruits the Werner syndrome (WRN) exonuclease for processing of telomeric DNA. Oncogene 23, 149156.
  • Marouga R, David S, Hawkins E (2005) The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal. Bioanal. Chem. 382, 669678.
  • Massip L, Garand C, Turaga RV, Deschenes F, Thorin E, Lebel M (2006) Increased insulin, triglycerides, reactive oxygen species, and cardiac fibrosis in mice with a mutation in the helicase domain of the Werner syndrome gene homologue. Exp. Gerontol. 41, 157168.
  • Moore G, Knoblaugh S, Gollahon K, Rabinovitch P, Ladiges W (2008) Hyperinsulinemia and insulin resistance in Wrn null mice fed a diabetogenic diet. Mech. Ageing Dev. 129, 201206.
  • Moser R, Toyoshima M, Robinson K, Gurley KE, Howie HL, Davison J, Morgan M, Kemp CJ, Grandori C (2012) MYC-driven tumorigenesis is inhibited by WRN syndrome gene deficiency. Mol. Cancer Res. 10, 535545.
  • Opresko PL, von Kobbe C, Laine JP, Harrigan J, Hickson ID, Bohr VA (2002) Telomere-binding protein TRF2 binds to and stimulates the Werner and Bloom syndrome helicases. J. Biol. Chem. 277, 4111041119.
  • Opresko PL, Otterlei M, Graakjaer J, Bruheim P, Dawut L, Kolvraa S, May A, Seidman MM, Bohr VA (2004) The Werner syndrome helicase and exonuclease cooperate to resolve telomeric D loops in a manner regulated by TRF1 and TRF2. Mol. Cell 14, 763774.
  • Opresko PL, Mason PA, Podell ER, Lei M, Hickson ID, Cech TR, Bohr VA (2005) POT1 stimulates RecQ helicases WRN and BLM to unwind telomeric DNA substrates. J. Biol. Chem. 280, 3206932080.
  • Opresko PL, Calvo JP, von Kobbe C (2007) Role for the Werner syndrome protein in the promotion of tumor cell growth. Mech. Ageing Dev. 128, 423436.
  • Pagano G, Zatterale A, Degan P, d'Ischia M, Kelly FJ, Pallardo FV, Calzone R, Castello G, Dunster C, Giudice A, Kilinc Y, Lloret A, Manini P, Masella R, Vuttariello E, Warnau M (2005) In vivo prooxidant state in Werner syndrome (WS): results from three WS patients and two WS heterozygotes. Free Radic Res. 39, 529533.
  • Parrinello S, Samper E, Krtolica A, Goldstein J, Melov S, Campisi J (2003) Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat. Cell Biol. 5, 741747.
  • Passos JF, Saretzki G, Ahmed S, Nelson G, Richter T, Peters H, Wappler I, Birket MJ, Harold G, Schaeuble K, Birch-Machin MA, Kirkwood TB, von Zglinicki T (2007) Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence. PLoS Biol. 5, e110.
  • Pause A, Belsham GJ, Gingras AC, Donze O, Lin TA, Lawrence JC Jr, Sonenberg N (1994) Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′-cap function. Nature 371, 762767.
  • Rossi ML, Ghosh AK, Bohr VA (2010) Roles of Werner syndrome protein in protection of genome integrity. DNA Repair (Amst) 9, 331344.
  • Salk D, Au K, Hoehn H, Martin GM (1985) Cytogenetic aspects of Werner syndrome. Adv. Exp. Med. Biol. 190, 541550.
  • Semenza GL (2011) Regulation of metabolism by hypoxia-inducible factor 1. Cold Spring Harb. Symp. Quant. Biol. 76, 347353.
  • Sena LA, Chandel NS (2012) Physiological roles of mitochondrial reactive oxygen species. Mol. Cell 48, 158167.
  • Seo AY, Joseph AM, Dutta D, Hwang JC, Aris JP, Leeuwenburgh C (2010) New insights into the role of mitochondria in aging: mitochondrial dynamics and more. J. Cell Sci. 123, 25332542.
  • Slupianek A, Poplawski T, Jozwiakowski SK, Cramer K, Pytel D, Stoczynska E, Nowicki MO, Blasiak J, Skorski T (2011) BCR/ABL stimulates WRN to promote survival and genomic instability. Cancer Res. 71, 842851.
  • Thomas GV, Tran C, Mellinghoff IK, Welsbie DS, Chan E, Fueger B, Czernin J, Sawyers CL (2006) Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer. Nat. Med. 12, 122127.
  • Thoreen CC, Chantranupong L, Keys HR, Wang T, Gray NS, Sabatini DM (2012) A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 485, 109113.
  • Trachootham D, Alexandre J, Huang P (2009) Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat. Rev. Drug Discovery 8, 579591.
  • Vercesi AE, Kowaltowski AJ, Grijalba MT, Meinicke AR, Castilho RF (1997) The role of reactive oxygen species in mitochondrial permeability transition. Biosci. Rep. 17, 4352.
  • Wang Z, Rhee DB, Lu J, Bohr CT, Zhou F, Vallabhaneni H, de Souza-Pinto NC, Liu Y (2010) Characterization of oxidative guanine damage and repair in mammalian telomeres. PLoS Genet. 6, e1000951.
  • Yee Koh M, Spivak-Kroizman TR, Powis G (2008) HIF-1 regulation: not so easy come, easy go. Trends Biochem. Sci. 33, 526534.
  • Yu CE, Oshima J, Fu YH, Wijsman EM, Hisama F, Alisch R, Matthews S, Nakura J, Miki T, Ouais S, Martin GM, Mulligan J, Schellenberg GD (1996) Positional cloning of the Werner's syndrome gene. Science 272, 258262.